Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.120 | 6 | 31616154 | non coding transcript exon variant | C/T | snv | 0.15 | 0.14 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.710 | 1.000 | 3 | 2007 | 2009 | ||||||
|
0.925 | 0.120 | 6 | 31616050 | 5 prime UTR variant | T/G | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.120 | 6 | 31616050 | 5 prime UTR variant | T/G | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.120 | 6 | 31616050 | 5 prime UTR variant | T/G | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.120 | 6 | 31616050 | 5 prime UTR variant | T/G | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 6 | 31615378 | intron variant | G/A | snv | 0.44 | 0.34 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 6 | 31615378 | intron variant | G/A | snv | 0.44 | 0.34 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 6 | 31615378 | intron variant | G/A | snv | 0.44 | 0.34 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 6 | 31615378 | intron variant | G/A | snv | 0.44 | 0.34 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.882 | 0.200 | 6 | 31617223 | upstream gene variant | T/A | snv | 0.74 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.120 | 6 | 31617442 | upstream gene variant | C/T | snv | 0.34 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.925 | 0.120 | 6 | 31617442 | upstream gene variant | C/T | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.120 | 6 | 31617442 | upstream gene variant | C/T | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.120 | 6 | 31617442 | upstream gene variant | C/T | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.925 | 0.120 | 6 | 31617442 | upstream gene variant | C/T | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
1.000 | 6 | 31615447 | intron variant | G/A | snv | 4.5E-02 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31615447 | intron variant | G/A | snv | 4.5E-02 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31615447 | intron variant | G/A | snv | 4.5E-02 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 6 | 31615447 | intron variant | G/A | snv | 4.5E-02 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 0.120 | 6 | 31614248 | upstream gene variant | G/C | snv | 0.18 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.120 | 6 | 31614248 | upstream gene variant | G/C | snv | 0.18 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.925 | 0.120 | 6 | 31616050 | 5 prime UTR variant | T/G | snv | 0.28 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||||
|
0.882 | 0.200 | 6 | 31617223 | upstream gene variant | T/A | snv | 0.74 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.882 | 0.200 | 6 | 31617223 | upstream gene variant | T/A | snv | 0.74 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 6 | 31616139 | missense variant | G/A;C | snv | 8.3E-06; 2.1E-05 |
|
Nutritional and Metabolic Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 |